The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial

• Status: Completed
• Trial end date: 0000-00-00
• Target enrollment: 7103
• Participant gender: Both

Summary

To investigate the safety of nitrous oxide (N2O) anaesthesia in patients with risk factors for coronary artery disease undergoing major surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayside Health
• Collaborator: National Health and Medical Research Council, Australia
• Treatments: Anesthetics; Nitrous Oxide
• Last Updated: 2013-09-24

Criteria

Inclusion Criteria

1. Adult males and females age ≥ 45 years, undergoing noncardiac surgery and general anaesthesia expected to exceed two hours.

2. At increased risk of cardiac events, defined as any of

1. history of coronary artery disease as defined by a history of any one of the following: i. angina ii. MI iii. segmental wall motion abnormality on echocardiography or a fixed defect on radionuclide imaging iv. a positive exercise stress test for cardiac ischaemia v. a positive radionuclide exercise, echocardiographic exercise, or pharmacological cardiovascular stress test for cardiac ischaemia vi. coronary revascularization (CABG or PTCA) vii. angiographic evidence of atherosclerotic stenosis > 50% of the diameter of any coronary artery viii. ECG with pathological Q waves in two contiguous leads

2. heart failure

3. cerebrovascular disease thought due to atherothrombotic disease

4. aortic or peripheral vascular disease

5. or three or more of the following risk factors:

• age ≥70 years

• any history of congestive heart failure

• diabetes and currently on an oral hypoglycaemic agent or insulin therapy

• current treatment for hypertension

• preoperative serum creatinine >175 micro mol/L (> 2.0 mg/dl)

• current or previous high cholesterol ≥6.2 mmol/L (> 240 mg/dl)

• history of a transient ischemic attack (TIA) (i.e. a transient focal neurological deficit that lasted less than 24 hours and thought to be vascular in origin)

• emergency/urgent surgery (i.e. surgery which must be undertaken within 24 hours of acute presentation to hospital)

• high-risk type of surgery (i.e. intrathoracic or intraperitoneal)

Exclusion Criteria

1. having cardiac surgery

2. marked impairment of gas-exchange expected to require Fi02> 0.5 intraoperatively

3. specific circumstances where N2O is contraindicated (eg. volvulus, pulmonary hypertension, raised intracranial pressure) or the anaesthetist plans to use supplemental oxygen (eg. colorectal surgery)

4. N2O unavailable for use.